These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 23924982)

  • 61. Compatibility and stability of linezolid injection admixed with aztreonam or piperacillin sodium.
    Zhang Y; Xu QA; Trissel LA; Williams KY
    J Am Pharm Assoc (Wash); 2000; 40(4):520-4. PubMed ID: 10932462
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Stability of flumazenil with selected drugs in 5% dextrose injection.
    Olsen KM; Gurley BJ; Davis GA; Christensen R; Monaghan MS
    Am J Hosp Pharm; 1993 Sep; 50(9):1907-12. PubMed ID: 8135238
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Compatibility of etoposide phosphate with selected drugs during simulated Y-site injection.
    Trissel LA; Martinez JF; Simmons M
    J Am Pharm Assoc (Wash); 1999; 39(2):141-5. PubMed ID: 10079649
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Stability of aminocaproic Acid injection admixtures in 5% dextrose injection and 0.9% sodium chloride injection.
    Zhang YP; Trissel LA
    Int J Pharm Compd; 1997; 1(2):132-4. PubMed ID: 23995973
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Compatibility of remifentanil hydrochloride with selected drugs during simulated Y-site administration.
    Trissel LA; Gilbert DL; Martinez JF; Kim MC
    Am J Health Syst Pharm; 1997 Oct; 54(19):2192-6. PubMed ID: 9331439
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Compatibility of gemcitabine hydrochloride with 107 selected drugs during simulated Y-site injection.
    Trissel LA; Martinez JF; Gilbert DL
    J Am Pharm Assoc (Wash); 1999; 39(4):514-8. PubMed ID: 10467816
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Compatibility and stability of ondansetron hydrochloride with morphine sulfate and with hydromorphone hydrochloride in 0.9% sodium chloride injection at 4, 22, and 32 degrees C.
    Trissel LA; Xu Q; Martinez JF; Fox JL
    Am J Hosp Pharm; 1994 Sep; 51(17):2138-42. PubMed ID: 7527184
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Compatibility screening of bivalirudin during simulated y-site administration with other drugs.
    Trissel LA; Saenz CA
    Int J Pharm Compd; 2002; 6(4):311-5. PubMed ID: 23979308
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Stability and compatibility of minocycline hydrochloride and rifampin in intravenous solutions at various temperatures.
    Pearson SD; Trissel LA
    Am J Hosp Pharm; 1993 Apr; 50(4):698-702. PubMed ID: 8470688
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Compatibility of filgrastim with selected drugs during simulated Y-site administration.
    Trissel LA; Martinez JF
    Am J Hosp Pharm; 1994 Aug; 51(15):1907-13. PubMed ID: 7524319
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Compatibility of esmolol hydrochloride with morphine sulfate and fentanyl citrate during simulated Y-site administration.
    Karnatz NN; Wong J; Kesler H; Baaske DM; Speicher ER
    Am J Hosp Pharm; 1988 Feb; 45(2):368-71. PubMed ID: 2896460
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Compatibility of aztreonam with selected drugs during simulated Y-site administration.
    Trissel LA; Martinez JF
    Am J Health Syst Pharm; 1995 May; 52(10):1086-90. PubMed ID: 7656099
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Compatibility of aminophylline and verapamil in intravenous admixtures.
    Johnson CE; Lloyd CW; Mesaros JL; Rubley GJ
    Am J Hosp Pharm; 1989 Jan; 46(1):97-100. PubMed ID: 2712035
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Stability of piperacillin sodium-tazobactam sodium and ranitidine hydrochloride in 0.9% sodium chloride injection during simulated Y-site administration.
    Choi JS; Burm JP; Jhee SS; Chin A; Ulrich RW; Gill MA
    Am J Hosp Pharm; 1994 Sep; 51(18):2273-6. PubMed ID: 7801988
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Compatibility screening of hextend during simulated y-site administration with other drugs.
    Trissel LA; Williams KY; Baker MB
    Int J Pharm Compd; 2001; 5(1):69-72. PubMed ID: 23981801
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Stability of dobutamine hydrochloride in peritoneal dialysis solutions.
    Gora ML; Seth S; Visconti JA; Shields B; Bay W
    Am J Hosp Pharm; 1991 Jun; 48(6):1234-7. PubMed ID: 1858802
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Stability of midazolam hydrochloride in a flavored, dye-free oral solution.
    Steedman SL; Koonce JR; Wynn JE; Brahen NH
    Am J Hosp Pharm; 1992 Mar; 49(3):615-8. PubMed ID: 1598938
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Physical compatibility of melphalan with selected drugs during simulated Y-site administration.
    Trissel LA; Martinez JF
    Am J Hosp Pharm; 1993 Nov; 50(11):2359-63. PubMed ID: 8266963
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Compatibility of midazolam hydrochloride and lorazepam with selected drugs during simulated Y-site administration.
    Swart EL; Mooren RA; van Loenen AC
    Am J Health Syst Pharm; 1995 Sep; 52(18):2020-2. PubMed ID: 8528872
    [No Abstract]   [Full Text] [Related]  

  • 80. The compatibility of a low concentration of hydrocortisone sodium succinate with selected drugs during a simulated Y-site administration.
    Semark AJ; Venkatesh K; McWhinney BC; Pretorius C; Roberts JA; Cohen J; Venkatesh B
    Crit Care Resusc; 2013 Mar; 15(1):63-6. PubMed ID: 23432505
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.